Publications 2025

Enden T (2025)
Healthcare speech for primary and specialist care
145 (2)
DOI 10.4045/tidsskr.25.0048, PubMed 39932082

Enden T (2025)
[Not Available]
145
DOI 10.4045/tidsskr.25.0121, PubMed 40042049

Svalastoga M, Larsen TL, Brekke J, Enden T, Frøen H, Garresori H, Jacobsen EM, Porojnicu AC, Ree AH, Torfoss D, Velle EO, Wik HS, Ghanima W, Sandset PM, Dahm AEA (2025)
Effect of drug interactions with apixaban on clinical outcomes in cancer patients with venous thromboembolism
15, 1520725
DOI 10.3389/fonc.2025.1520725, PubMed 39931081

Publications 2024

Enden T (2024)
Have a pretty radiant day!
144 (2)
DOI 10.4045/tidsskr.24.0049, PubMed 38349095

Enden T (2024)
[Not Available]
144
DOI 10.4045/tidsskr.24.0110, PubMed 38506168

Enden T (2024)
On the dating market
144 (7)
DOI 10.4045/tidsskr.24.0286, PubMed 38832600

Enden T (2024)
Included patients and integrated clinical treatment trials
144 (14)
DOI 10.4045/tidsskr.24.0564, PubMed 39605149

Enden T (2024)
[Not Available]
144
DOI 10.4045/tidsskr.24.0596, PubMed 39606795

Publications 2023

Enden T (2023)
In training or at work?
143 (2)
DOI 10.4045/tidsskr.23.0031, PubMed 36718885

Enden T (2023)
Equality under the Health Research Act
143 (9)
DOI 10.4045/tidsskr.23.0386, PubMed 37341395

Enden T (2023)
Peer reviewers, commonship and ownership
143 (17)
DOI 10.4045/tidsskr.23.0751, PubMed 37987061

Enden T (2023)
[Not Available]
143
DOI 10.4045/tidsskr.23.0843, PubMed 38372223

Larsen TL, Svalastoga M, Brekke J, Enden T, Frøen H, Garresori H, Jacobsen EM, Paulsen PQ, Porojnicu AC, Ree AH, Torfoss D, Velle EO, Wik HS, Ghanima W, Sandset PM, Dahm AEA (2023)
Arterial events in cancer patients treated with apixaban for venous thrombosis
228, 128-133
DOI 10.1016/j.thromres.2023.05.017, PubMed 37327527

Publications 2022

Enden T (2022)
[Not Available]
142
DOI 10.4045/tidsskr.22.0656, PubMed 36303471

Larsen TL, Garresori H, Brekke J, Enden T, Frøen H, Jacobsen EM, Quist-Paulsen P, Porojnicu AC, Ree AH, Torfoss D, Osvik Velle E, Skuterud Wik H, Ghanima W, Sandset PM, Dahm AEA (2022)
Low dose apixaban as secondary prophylaxis of venous thromboembolism in cancer patients - 30 months follow-up
20 (5), 1166-1181
DOI 10.1111/jth.15666, PubMed 35114046

Larsen TL, Garresori H, Brekke J, Enden T, Frøen H, Jacobsen EM, Quist-Paulsen P, Porojnicu AC, Ree AH, Torfoss D, Velle EO, Wik HS, Ghanima W, Sandset PM, Dahm AEA (2022)
"Low dose apixaban as secondary prophylaxis of venous thromboembolism in cancer patients - 30 months follow-up": Reply
20 (8), 1937-1939
DOI 10.1111/jth.15774, PubMed 35859282

Publications 2021

Engeseth M, Enden T, Sandset PM, Wik HS (2021)
Predictors of long-term post-thrombotic syndrome following high proximal deep vein thrombosis: a cross-sectional study
19 (1), 3
DOI 10.1186/s12959-020-00253-8, PubMed 33419441

Publications 2020

Hannevik TL, Brekke J, Enden T, Frøen H, Garresori H, Jacobsen EM, Paulsen PQ, Porojnicu AC, Ree AH, Torfoss D, Velle EO, Wik HS, Ghanima W, Sandset PM, Dahm AEA (2020)
Thrombosis and bleedings in a cohort of cancer patients treated with apixaban for venous thromboembolism
196, 238-244
DOI 10.1016/j.thromres.2020.08.042, PubMed 32919178

Publications 2019

Engeseth M, Enden T, Andersen MH, Sandset PM, Wik HS (2019)
Does the Villalta scale capture the essence of postthrombotic syndrome? A qualitative study of patient experience and expert opinion
17 (10), 1707-1714
DOI 10.1111/jth.14557, PubMed 31265193

Engeseth M, Enden T, Sandset PM, Wik HS (2019)
Limitations of the Villalta scale in diagnosing post-thrombotic syndrome
184, 62-66
DOI 10.1016/j.thromres.2019.10.018, PubMed 31707153

Publications 2018

Enden T, Bernklev T, Jelsness-Jorgensen LP, Amdal CD (2018)
Patients know their own health best
Tidsskr. Nor. Laegeforen., 138 (8), 716-718

Enden T, Bernklev T, Jelsness-Jørgensen LP, Amdal CD (2018)
[Patients know their own health best]
138 (8)
DOI 10.4045/tidsskr.17.1054, PubMed 29737772

Grøtta O, Enden T, Sandbæk G, Gjerdalen GF, Slagsvold CE, Bay D, Kløw NE, Rosales A (2018)
Infrainguinal inflow assessment and endovenous stent placement in iliofemoral post-thrombotic obstructions
1 (1), 29
DOI 10.1186/s42155-018-0038-9, PubMed 30652160

Publications 2017

Ghanima W, Wik HS, Tavoly M, Enden T, Jelsness-Jørgensen LP (2017)
Late consequences of venous thromboembolism: Measuring quality of life after deep vein thrombosis and pulmonary embolism
164, 170-176
DOI 10.1016/j.thromres.2017.07.025, PubMed 28760416

Grøtta O, Enden T, Sandbæk G, Gjerdalen GF, Slagsvold CE, Bay D, Kløw NE, Rosales A (2017)
Patency and Clinical Outcome After Stent Placement for Chronic Obstruction of the Inferior Vena Cava
54 (5), 620-628
DOI 10.1016/j.ejvs.2017.07.003, PubMed 28797661

Publications 2016

Haig Y, Enden T, Grøtta O, Kløw NE, Slagsvold CE, Ghanima W, Sandvik L, Hafsahl G, Holme PA, Holmen LO, Njaaastad AM, Sandbæk G, Sandset PM, CaVenT Study Group (2016)
Post-thrombotic syndrome after catheter-directed thrombolysis for deep vein thrombosis (CaVenT): 5-year follow-up results of an open-label, randomised controlled trial
3 (2), e64-71
DOI 10.1016/S2352-3026(15)00248-3, PubMed 26853645

Young VS, Eggesbø HB, Gaarder C, Næss PA, Enden T (2016)
Radiology response in the emergency department during a mass casualty incident: a retrospective study of the two terrorist attacks on 22 July 2011 in Norway
27 (7), 2828-2834
DOI 10.1007/s00330-016-4677-8, PubMed 27957642

Publications 2015

Young VS, Viktil E, Løberg EM, Enden T (2015)
Benign metastasizing pleomorphic adenoma in liver mimicking synchronic metastatic disease from colorectal cancer: a case report with emphasis on imaging findings
4 (8), 2058460115594199
DOI 10.1177/2058460115594199, PubMed 26331091

Publications 2014

Haig Y, Enden T, Slagsvold CE, Sandvik L, Sandset PM, Kløw NE (2014)
Residual rates of reflux and obstruction and their correlation to post-thrombotic syndrome in a randomized study on catheter-directed thrombolysis for deep vein thrombosis
2 (2), 123-30
DOI 10.1016/j.jvsv.2013.10.054, PubMed 26993176

Publications 2013

Enden T, Kløw NE, Sandset PM (2013)
Symptom burden and job absenteeism after treatment with additional catheter-directed thrombolysis for deep vein thrombosis
4, 55-9
DOI 10.2147/PROM.S47233, PubMed 24082798

Enden T, Resch S, White C, Wik HS, Kløw NE, Sandset PM (2013)
Cost-effectiveness of additional catheter-directed thrombolysis for deep vein thrombosis
11 (6), 1032-42
DOI 10.1111/jth.12184, PubMed 23452204

Enden T, Wik HS, Kvam AK, Haig Y, Kløw NE, Sandset PM (2013)
Health-related quality of life after catheter-directed thrombolysis for deep vein thrombosis: secondary outcomes of the randomised, non-blinded, parallel-group CaVenT study
3 (8), e002984
DOI 10.1136/bmjopen-2013-002984, PubMed 23988361

Publications 2012

Enden T, Klow NE, Sandset PM (2012)
Catheter-directed thrombolysis for acute deep vein thrombosis Reply
Lancet, 379 (9828), 1786-1787
DOI 10.1016/S0140-6736(12)60754-5

Enden T, Sandset PM, Kløw NE (2012)
Evidence-based practice for patients with severe venous thrombosis
132 (10), 1215-6
DOI 10.4045/tidsskr.12.0474, PubMed 22669381

Haig Y, Enden T, Slagsvold CE, Sandvik L, Sandset PM, Kløw NE (2012)
Determinants of early and long-term efficacy of catheter-directed thrombolysis in proximal deep vein thrombosis
24 (1), 17-24; quiz 26
DOI 10.1016/j.jvir.2012.09.023, PubMed 23176966

Publications 2011

Enden T, Haig Y, Kløw NE, Slagsvold CE, Sandvik L, Ghanima W, Hafsahl G, Holme PA, Holmen LO, Njaastad AM, Sandbæk G, Sandset PM, CaVenT Study Group (2011)
Long-term outcome after additional catheter-directed thrombolysis versus standard treatment for acute iliofemoral deep vein thrombosis (the CaVenT study): a randomised controlled trial
379 (9810), 31-8
DOI 10.1016/S0140-6736(11)61753-4, PubMed 22172244

Ghanima W, Kleven IW, Enden T, Rosales A, Wik HS, Pederstad L, Holme PA, Sandset PM (2011)
Recurrent venous thrombosis, post-thrombotic syndrome and quality of life after catheter-directed thrombolysis in severe proximal deep vein thrombosis
9 (6), 1261-3
DOI 10.1111/j.1538-7836.2011.04298.x, PubMed 21489133

Publications 2010

Enden T, Storås TH, Negård A, Haig Y, Sandvik L, Gjesdal KI, Sandset PM, Kløw NE (2010)
Visualization of deep veins and detection of deep vein thrombosis (DVT) with balanced turbo field echo (b-TFE) and contrast-enhanced T1 fast field echo (CE-FFE) using a blood pool agent (BPA)
31 (2), 416-24
DOI 10.1002/jmri.22046, PubMed 20099355

Publications 2009

Enden T, Kløw NE, Sandvik L, Slagsvold CE, Ghanima W, Hafsahl G, Holme PA, Holmen LO, Njaastad AM, Sandbaek G, Sandset PM, CaVenT study group (2009)
Catheter-directed thrombolysis vs. anticoagulant therapy alone in deep vein thrombosis: results of an open randomized, controlled trial reporting on short-term patency
7 (8), 1268-75
DOI 10.1111/j.1538-7836.2009.03464.x, PubMed 19422443

Publications 2008

Enden T, Garratt AM, Kløw NE, Sandset PM (2008)
Assessing burden of illness following acute deep vein thrombosis: data quality, reliability and validity of the Norwegian version of VEINES-QOL/Sym, a disease-specific questionnaire
23 (2), 369-74
DOI 10.1111/j.1471-6712.2008.00618.x, PubMed 19068041

Publications 2007

Enden T, Sandvik L, Kløw NE, Hafsahl G, Holme PA, Holmen LO, Ghanima W, Njaastad AM, Sandbaek G, Slagsvold CE, Sandset PM (2007)
Catheter-directed Venous Thrombolysis in acute iliofemoral vein thrombosis--the CaVenT study: rationale and design of a multicenter, randomized, controlled, clinical trial (NCT00251771)
154 (5), 808-14
DOI 10.1016/j.ahj.2007.07.010, PubMed 17967583

Publications 2006

Enden T, Kløw NE, Sandset PM (2006)
[Catheter-directed thrombolysis in acute deep venous thrombosis]
126 (13), 1765
PubMed 16794675

Johnson E, Enden T, Noreng HJ, Holck-Steen A, Gjerlaug BE, Morken T, Johannessen HO, Drolsum A (2006)
Survival and complications after insertion of self-expandable metal stents for malignant oesophageal stenosis
41 (3), 252-6
DOI 10.1080/00365520500206350, PubMed 16497610

Publications 2005

Johnson E, Gjerlaug BE, Holck-Steen A, Johannessen HO, Carlsen E, Enden T, Noreng HJ, Drolsum A (2005)
[Surgery and stenting for oesophageal cancer]
125 (3), 286-8
PubMed 15702148

Publications 2003

Enden T, Klow NE (2003)
Ct pulmonary angiography and suspected acute pulmonary embolism
Acta Radiol., 44 (3), 310-315
DOI 10.1034/j.1600-0455.2003.00074.x

Enden T, Kløw NE (2003)
CT pulmonary angiography and suspected acute pulmonary embolism
44 (3), 310-5
DOI 10.1080/j.1600-0455.2003.00074.x, PubMed 12752003

Publications 1995

Breivik HB, Sørdal JO, Myhre MC, Lyseggen E, Halvorsen JA, Enden T (1995)
Skjult alkoholmisbruk hos kvinne : læringsoppgave nr. 66 i samfunnsmedisinske fag
[S. n.], [S. l.], 30 bl.
BIBSYS 000459917

Røttingen JA, Enden T, Camerer E, Iversen JG, Prydz H (1995)
Binding of human factor VIIa to tissue factor induces cytosolic Ca2+ signals in J82 cells, transfected COS-1 cells, Madin-Darby canine kidney cells and in human endothelial cells induced to synthesize tissue factor
270 (9), 4650-60
DOI 10.1074/jbc.270.9.4650, PubMed 7876236

Publications 1994

Narahara N, Enden T, Wiiger M, Prydz H (1994)
Polar expression of tissue factor in human umbilical vein endothelial cells
14 (11), 1815-20
DOI 10.1161/01.atv.14.11.1815, PubMed 7947608